Epstein-Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement [1]

Annals of Hematology

Volumn 84, Issue 7, 2005, Pages 477-478

  Krüger, William H ^a   Schüler, Frank ^a   Lotze, Christian ^a   Schwesinger, Gun̈ther ^a   Mentel, Renate ^a   Busemann, Christoph ^a   Dölken, Gottfried ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; THYMOCYTE ANTIBODY; TREOSULFAN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOPSY; CANCER RELAPSE; CANCER STAGING; CASE REPORT; DEATH; EPSTEIN BARR VIRUS; FEVER; GRAFT VERSUS HOST REACTION; HEPATITIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOHISTOLOGY; KIDNEY FAILURE; LETTER; LIVER BIOPSY; LIVER TOXICITY; LUNG INSUFFICIENCY; LYMPHADENOPATHY; MALAISE; MALE; MICROBIOLOGICAL EXAMINATION; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REACTIVATION;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 20944447212     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1010-z     Document Type: Letter

References (14)

1. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529
2. Meijer E, Slaper-Cortenbach IC, Thijsen SF, Dekker AW, Verdonck LF (2002) Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 29:335-339
3. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 94:2208-2216
4. Gross TG, Loechelt BJ (2003) Epstein-Barr virus associated disease following blood or marrow transplant. Pediatr Transplant 7 [Suppl 3]:44-50
5. Micallef IN, Chhanabhai M, Gascoyne RD, Shepherd JD, Fung HC, Nantel SH, Toze CL, Klingemann HG, Sutherland HJ, Hogge DE, Nevill TJ, Le A, Barnett MJ (1998) Lymphoproliferative disorders following allogeneic bone marrow transplantation: The Vancouver experience. Bone Marrow Transplant 22:981-987
6. Juvonen E, Aalto SM, Tarkkanen J, Volin L, Mattila PS, Knuutila S, Ruutu T, Hedman K (2003) High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant 32:97-102
7. Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U, Wegener R, Kleine HD, Wilhelm S, Knopp A, Hartung G, Dölken G, Freund M (2004) Treosulfan and fludarabine: A new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 103:725-731
8. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562-1568
9. Loughrey M, Trivett M, Lade S, Murray W, Turner H, Waring P (2004) Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation. Pathology 36:301-308
10. Niesters HG (2004) Molecular and diagnostic clinical virology in real time. Clin Microbiol Infect 10:5-11
11. Krüger WH, Hornung RJ, Hertenstein B, Kern WV, Kröger N, Ljungman P, Zander AR (2001) Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: A survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res 10:895-903
12. Wagner HJ, Rooney CM, Heslop HE (2002) Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8:1-8
13. O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L (1997) Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev 157:195-216
14. Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahan L, Steinberg S, Woodle ES, Chan L, Ham JM, Schroeder TJ (1998) Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 66:29-37